• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG PET/CT 测量的肿瘤体积表面积比估计的肿瘤碎裂是弥漫性大 B 细胞淋巴瘤的独立预后因素。

Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma.

机构信息

Department of Nuclear Medicine, Henri Becquerel Cancer Centre, Rue d'Amiens - CS 11516, 76038, Rouen Cedex 1, France.

LITIS Quantif-EA4108, University of Rouen, Rouen, France.

出版信息

Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1672-1679. doi: 10.1007/s00259-018-4041-0. Epub 2018 Apr 28.

DOI:10.1007/s00259-018-4041-0
PMID:29705879
Abstract

INTRODUCTION

Our aim was to study the prognostic value of two new F-FDG PET biomarkers in diffuse large B-cell lymphoma (DLBCL). We examined the total tumor surface (TTS), describing the tumor-host interface, and the tumor volume surface ratio (TVSR), corresponding to the ratio between the total metabolic tumor volume (TMTV) and TTS, describing the tumor fragmentation.

METHODS

We retrospectively included 215 patients with DLBCL. Patients underwent initial F-FDG PET/CT before R-CHOP (73%) or intensified R-CHOP (R-ACVBP) regimens (27%). The TMTV was measured using a fixed threshold value of 41% of SUVmax. To calculate TTS and TVSR, the surface was measured using an in-house software based on the marching cube algorithm. Spearman's rank correlation coefficient (ρ) was computed between TMTV, TTS, and TVSR, and ROC analysis was performed. Survival functions at 5 years were studied using a Kaplan-Meier method and uni/multivariate Cox analysis.

RESULTS

TVSR was poorly correlated with TMTV (ρ = 0.5) and TTS (ρ = 0.26), while TTS was highly correlated with TMTV (ρ = 0.94) and was, therefore, excluded from the analysis. TMTV had the highest area under the ROC curve (0.711) and the best sensitivity (0.797), while TVSR had the best specificity (0.745). The optimal cut-off values to predict 5-year OS were 222 cm for TMTV and 6.0 mm for TVSR. Patients with high TMTV and TVSR had significantly worse prognosis in Kaplan-Meier and Cox univariate analysis. In a multivariate Cox analysis combining the International Prognostic Index (IPI), the type of chemotherapy, TMTV, and TVSR, all parameters were independent and significant prognostic factors (HR [95%CI]: IPI 1.4 [1.1-1.8], type of chemotherapy 4.5 [2.0-10.5], TMTV 2.8 [1.4-5.5], TVSR 2.1 [1.3-3.4]). A synergistic effect between TMTV and TVSR was observed in a Kaplan-Meier analysis combining the two parameters.

CONCLUSIONS

TVSR measured on the initial F-FDG PET is an independent prognostic factor in DLBCL and has an additional prognostic value when combined with TMTV, IPI score and chemotherapy.

摘要

简介

我们的目的是研究两种新的 F-FDG PET 生物标志物在弥漫性大 B 细胞淋巴瘤 (DLBCL) 中的预后价值。我们研究了总肿瘤表面积 (TTS),用于描述肿瘤-宿主界面,以及肿瘤体积表面积比 (TVSR),它对应于总代谢肿瘤体积 (TMTV)与 TTS 的比值,用于描述肿瘤碎裂程度。

方法

我们回顾性纳入了 215 例 DLBCL 患者。患者在 R-CHOP(73%)或强化 R-CHOP(R-ACVBP)方案(27%)之前接受了初始 F-FDG PET/CT 检查。使用 SUVmax 的 41%的固定阈值来测量 TMTV。为了计算 TTS 和 TVSR,使用基于体素空间填充算法的内部软件测量表面积。使用 Spearman 秩相关系数 (ρ) 计算 TMTV、TTS 和 TVSR 之间的相关性,并进行 ROC 分析。使用 Kaplan-Meier 方法和单变量/多变量 Cox 分析研究 5 年生存功能。

结果

TVSR 与 TMTV(ρ=0.5)和 TTS(ρ=0.26)的相关性较差,而 TTS 与 TMTV 高度相关(ρ=0.94),因此排除在分析之外。TMTV 具有最高的 ROC 曲线下面积 (0.711) 和最佳敏感性 (0.797),而 TVSR 具有最佳特异性 (0.745)。预测 5 年 OS 的最佳截断值为 TMTV 为 222cm,TVSR 为 6.0mm。Kaplan-Meier 和 Cox 单变量分析显示,TMTV 和 TVSR 较高的患者预后明显较差。在多变量 Cox 分析中,将国际预后指数 (IPI)、化疗类型、TMTV 和 TVSR 结合在一起,所有参数均为独立且重要的预后因素(HR [95%CI]:IPI 1.4 [1.1-1.8],化疗类型 4.5 [2.0-10.5],TMTV 2.8 [1.4-5.5],TVSR 2.1 [1.3-3.4])。在结合两个参数的 Kaplan-Meier 分析中观察到 TMTV 和 TVSR 之间的协同作用。

结论

在 DLBCL 中,初始 F-FDG PET 上测量的 TVSR 是独立的预后因素,与 TMTV、IPI 评分和化疗联合具有额外的预后价值。

相似文献

1
Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma.18F-FDG PET/CT 测量的肿瘤体积表面积比估计的肿瘤碎裂是弥漫性大 B 细胞淋巴瘤的独立预后因素。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1672-1679. doi: 10.1007/s00259-018-4041-0. Epub 2018 Apr 28.
2
Prognostic value of metabolic tumour volume on baseline F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI.基线 F-FDG PET/CT 代谢肿瘤体积对弥漫性大 B 细胞淋巴瘤患者 NCCN-IPI 的预后价值:对高危 NCCN-IPI 组的进一步分层。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1417-1427. doi: 10.1007/s00259-019-04309-4. Epub 2019 Apr 2.
3
Metabolic tumour area: a novel prognostic indicator based on F-FDG PET/CT in patients with diffuse large B-cell lymphoma in the R-CHOP era.代谢肿瘤区:基于 F-FDG PET/CT 的新型预后指标,可用于 R-CHOP 时代弥漫性大 B 细胞淋巴瘤患者。
BMC Cancer. 2024 Jul 25;24(1):895. doi: 10.1186/s12885-024-12668-x.
4
[Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].[预处理(18)F-FDG PET-CT对晚期弥漫性大B细胞淋巴瘤患者的预后价值]
Zhonghua Zhong Liu Za Zhi. 2018 Jul 23;40(7):528-533. doi: 10.3760/cma.j.issn.0253-3766.2018.07.009.
5
A better prediction of progression-free survival in diffuse large B-cell lymphoma by a prognostic model consisting of baseline TLG and %ΔSUV.由基线 TLG 和 %ΔSUV 组成的预后模型可更好地预测弥漫性大 B 细胞淋巴瘤的无进展生存期。
Cancer Med. 2019 Sep;8(11):5137-5147. doi: 10.1002/cam4.2284. Epub 2019 Jul 25.
6
[F-FDG PET/CT Metabolic Parameters and Circulating Tumour DNA Mutation Abundance in Diffuse Large B-Cell Lymphoma: Correlation and Survival Analysis].[弥漫性大B细胞淋巴瘤中F-FDG PET/CT代谢参数与循环肿瘤DNA突变丰度:相关性及生存分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Dec;31(6):1690-1700. doi: 10.19746/j.cnki.issn.1009-2137.2023.06.014.
7
Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.基线 FDG PET/CT 总代谢肿瘤体积与基因表达谱联合具有弥漫性大 B 细胞淋巴瘤患者强有力的预测价值。
Eur J Nucl Med Mol Imaging. 2018 May;45(5):680-688. doi: 10.1007/s00259-017-3907-x. Epub 2018 Jan 17.
8
Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma.弥漫性大 B 细胞淋巴瘤患者的分子谱和 FDG-PET/CT 总代谢肿瘤体积改善了诊断时的风险分类。
Clin Cancer Res. 2016 Aug 1;22(15):3801-9. doi: 10.1158/1078-0432.CCR-15-2825. Epub 2016 Mar 2.
9
Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma.基线 FDG PET 上测量的体积、质量和碎裂参数的组合对高负担滤泡性淋巴瘤的预后价值。
Sci Rep. 2024 Apr 5;14(1):8033. doi: 10.1038/s41598-024-58412-0.
10
Serum level of soluble interleukin-2 receptor is positively correlated with metabolic tumor volume on F-FDG PET/CT in newly diagnosed patients with diffuse large B-cell lymphoma.血清可溶性白细胞介素-2 受体水平与初诊弥漫性大 B 细胞淋巴瘤患者 F-FDG PET/CT 上的代谢肿瘤体积呈正相关。
Cancer Med. 2019 Mar;8(3):953-962. doi: 10.1002/cam4.1973. Epub 2019 Feb 20.

引用本文的文献

1
Divergent prognostic utility of metabolic risk scores in large B-cell lymphoma subtypes: a real-world analysis.代谢风险评分在大B细胞淋巴瘤亚型中的不同预后效用:一项真实世界分析
Eur J Nucl Med Mol Imaging. 2025 Jun 16. doi: 10.1007/s00259-025-07368-y.
2
Enhancing Lymphoma Diagnosis, Treatment, and Follow-Up Using F-FDG PET/CT Imaging: Contribution of Artificial Intelligence and Radiomics Analysis.利用F-FDG PET/CT成像增强淋巴瘤的诊断、治疗及随访:人工智能和影像组学分析的贡献
Cancers (Basel). 2024 Oct 17;16(20):3511. doi: 10.3390/cancers16203511.
3
Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma.

本文引用的文献

1
Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study.高肿瘤负荷滤泡淋巴瘤的预后模型整合基线和诱导后 PET:LYSA/FIL 研究。
Blood. 2018 May 31;131(22):2449-2453. doi: 10.1182/blood-2017-11-816298. Epub 2018 Mar 20.
2
Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma.定义弥漫性大 B 细胞淋巴瘤基线代谢肿瘤体积的最佳测量方法。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1142-1154. doi: 10.1007/s00259-018-3953-z. Epub 2018 Feb 19.
3
Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.
基线 FDG PET 上测量的体积、质量和碎裂参数的组合对高负担滤泡性淋巴瘤的预后价值。
Sci Rep. 2024 Apr 5;14(1):8033. doi: 10.1038/s41598-024-58412-0.
4
Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy.描述肿瘤病灶聚集和播散的指标及其对接受嵌合抗原受体 T 细胞治疗的弥漫性大 B 细胞淋巴瘤患者预后的影响。
Cancer Med. 2024 Mar;13(6):e6991. doi: 10.1002/cam4.6991.
5
Prognostic value of whole-body dynamic F-FDG PET/CT Patlak in diffuse large B-cell lymphoma.全身动态F-FDG PET/CT Patlak在弥漫性大B细胞淋巴瘤中的预后价值
Heliyon. 2023 Sep 1;9(9):e19749. doi: 10.1016/j.heliyon.2023.e19749. eCollection 2023 Sep.
6
Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells.基于放射组学-临床列线图预测嵌合抗原受体 T 细胞治疗弥漫性大 B 细胞淋巴瘤患者生存情况的研究。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11549-11560. doi: 10.1007/s00432-023-05038-w. Epub 2023 Jul 3.
7
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.比较病灶和特征选择,以预测 FDG PET/CT 放射组学特征的初诊弥漫性大 B 细胞淋巴瘤患者的进展情况。
Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4642-4651. doi: 10.1007/s00259-022-05916-4. Epub 2022 Aug 4.
8
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYA.一种将PET衍生指标和图像纹理分析与来自GOYA的临床风险因素相结合的预后模型。
EJHaem. 2022 Mar 24;3(2):406-414. doi: 10.1002/jha2.421. eCollection 2022 May.
9
Discovery of Pre-Treatment FDG PET/CT-Derived Radiomics-Based Models for Predicting Outcome in Diffuse Large B-Cell Lymphoma.发现基于预处理氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)影像组学的模型用于预测弥漫性大B细胞淋巴瘤的预后
Cancers (Basel). 2022 Mar 28;14(7):1711. doi: 10.3390/cancers14071711.
10
Gross Tumor Volume Definition and Comparative Assessment for Esophageal Squamous Cell Carcinoma From 3D F-FDG PET/CT by Deep Learning-Based Method.基于深度学习方法的3D F-FDG PET/CT对食管鳞状细胞癌的肿瘤总体积定义及比较评估
Front Oncol. 2022 Mar 17;12:799207. doi: 10.3389/fonc.2022.799207. eCollection 2022.
基线 FDG PET/CT 总代谢肿瘤体积与基因表达谱联合具有弥漫性大 B 细胞淋巴瘤患者强有力的预测价值。
Eur J Nucl Med Mol Imaging. 2018 May;45(5):680-688. doi: 10.1007/s00259-017-3907-x. Epub 2018 Jan 17.
4
Association between textural and morphological tumor indices on baseline PET-CT and early metabolic response on interim PET-CT in bulky malignant lymphomas.基线 PET-CT 的纹理和形态肿瘤指标与大肿块恶性淋巴瘤中中期 PET-CT 的早期代谢反应之间的关联。
Med Phys. 2017 Sep;44(9):4608-4619. doi: 10.1002/mp.12349. Epub 2017 Aug 2.
5
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.用于霍奇金淋巴瘤和非霍奇金淋巴瘤治疗监测的氟代脱氧葡萄糖正电子发射断层显像(FDG PET)
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):97-110. doi: 10.1007/s00259-017-3690-8. Epub 2017 Apr 14.
6
PET-CT for Evaluation of Spleen and Liver 18F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma.PET-CT用于评估淋巴瘤中脾脏和肝脏18F-FDG弥漫性摄取且无淋巴结肿大的情况。
Medicine (Baltimore). 2016 May;95(20):e3750. doi: 10.1097/MD.0000000000003750.
7
Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma.弥漫性大 B 细胞淋巴瘤患者的分子谱和 FDG-PET/CT 总代谢肿瘤体积改善了诊断时的风险分类。
Clin Cancer Res. 2016 Aug 1;22(15):3801-9. doi: 10.1158/1078-0432.CCR-15-2825. Epub 2016 Mar 2.
8
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.弥漫性大B细胞淋巴瘤(DLBCL):ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2015 Sep;26 Suppl 5:v116-25. doi: 10.1093/annonc/mdv304.
9
Predictive value of F-18 FDG PET/CT quantization parameters for progression-free survival in patients with diffuse large B-cell lymphoma.F-18 FDG PET/CT量化参数对弥漫性大B细胞淋巴瘤患者无进展生存期的预测价值
Hematology. 2016 Mar;21(2):99-105. doi: 10.1179/1607845415Y.0000000033. Epub 2015 Jul 17.
10
False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review.正电子发射断层显像(PET)和计算机断层扫描(CT)纹理特征研究中的错误发现率:一项系统评价
PLoS One. 2015 May 4;10(5):e0124165. doi: 10.1371/journal.pone.0124165. eCollection 2015.